$MMEX
MMEX Resources Corp Stock $mmex

$mmex Overview Financials Valuation SEC Filings Company Website

2023 Q3 Form 10-Q Financial Statement

#000147793223006808 Filed on September 11, 2023

Income Statement

Concept	2023 Q3	2022 Q3
Revenue	$0.00	$0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$324.0K	$803.9K
YoY Change	-59.69%	81.66%
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$9.100K	$9.100K
YoY Change	0.0%	4.36%
% of Gross Profit
Operating Expenses	$333.1K	$817.3K
YoY Change	-59.24%	79.91%
Operating Profit	-$333.1K	-$817.3K
YoY Change	-59.24%	79.91%
Interest Expense	$99.14K	-$62.89K
YoY Change	-257.64%	-102.24%
% of Operating Profit
Other Income/Expense, Net	-$852.4K	-$46.35K
YoY Change	1739.21%	-101.69%
Pretax Income	-$1.186M	-$863.7K
YoY Change	37.27%	-137.69%
Income Tax	$0.00	$0.00
% Of Pretax Income
Net Earnings	-$1.186M	-$863.7K
YoY Change	37.27%	-137.69%
Net Earnings / Revenue
Basic Earnings Per Share		-$0.15
Diluted Earnings Per Share	$0.00	-$0.15
COMMON SHARES
Basic Shares Outstanding	4.541B shares	23.31M shares
Diluted Shares Outstanding		22.56M shares

Balance Sheet

Concept	2023 Q3	2022 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$250.00	$8.260K
YoY Change	-96.97%	-99.52%
Cash & Equivalents	$250.00	$8.259K
Short-Term Investments
Other Short-Term Assets	$3.000K	$29.83K
YoY Change	-89.94%	-91.0%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets	$3.250K	$38.09K
YoY Change	-91.47%	-98.15%
LONG-TERM ASSETS
Property, Plant & Equipment	$1.069M	$1.105M
YoY Change	-3.29%	55.9%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets	$1.069M	$1.105M
YoY Change	-3.29%	55.7%
TOTAL ASSETS
Total Short-Term Assets	$3.250K	$38.09K
Total Long-Term Assets	$1.069M	$1.105M
Total Assets	$1.072M	$1.143M
YoY Change	-6.23%	-58.78%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$754.4K	$662.9K
YoY Change	13.8%	-16.82%
Accrued Expenses	$1.049M	$864.2K
YoY Change	21.4%	2.44%
Deferred Revenue
YoY Change
Short-Term Debt	$1.790M	$1.524M
YoY Change	17.44%	-6.19%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$4.025M	$3.158M
YoY Change	27.45%	-11.26%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$0.00
YoY Change
Total Long-Term Liabilities	$0.00	$0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities	$4.025M	$3.158M
Total Long-Term Liabilities	$0.00	$0.00
Total Liabilities	$4.025M	$3.158M
YoY Change	27.45%	-11.26%
SHAREHOLDERS EQUITY
Retained Earnings	-$73.91M	-$71.61M
YoY Change	3.21%	9.01%
Common Stock	$4.881M	$24.41K
YoY Change	19897.37%	559.55%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$2.953M	-$2.015M
YoY Change
Total Liabilities & Shareholders Equity	$1.072M	$1.143M
YoY Change	-6.23%	-58.78%

Cashflow Statement

Concept	2023 Q3	2022 Q3
OPERATING ACTIVITIES
Net Income	-$1.186M	-$863.7K
YoY Change	37.27%	-137.69%
Depreciation, Depletion And Amortization	$9.100K	$9.100K
YoY Change	0.0%	4.36%
Cash From Operating Activities	-$75.51K	-$233.6K
YoY Change	-67.68%	-71.75%
INVESTING ACTIVITIES
Capital Expenditures	$0.00	$0.00
YoY Change		-100.0%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities	$0.00	$0.00
YoY Change		-100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	$65.40K	$105.0K
YoY Change	-37.71%	-95.76%
NET CHANGE
Cash From Operating Activities	-$75.51K	-$233.6K
Cash From Investing Activities	$0.00	$0.00
Cash From Financing Activities	$65.40K	$105.0K
Net Change In Cash	-$10.11K	-$128.6K
YoY Change	-92.14%	-109.17%
FREE CASH FLOW
Cash From Operating Activities	-$75.51K	-$233.6K
Capital Expenditures	$0.00	$0.00
Free Cash Flow	-$75.51K	-$233.6K
YoY Change	-67.68%	-59.82%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-863660	usd
CY2023Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
CY2023Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	250	usd
CY2023Q3	us-gaap	Accounts Payable And Other Accrued Liabilities AccountsPayableAndOtherAccruedLiabilities	431286	usd
CY2023Q2	us-gaap	Accounts Payable And Other Accrued Liabilities AccountsPayableAndOtherAccruedLiabilities	465703	usd
CY2023Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	324039	usd
CY2023Q3	us-gaap	Depreciation And Amortization DepreciationAndAmortization	9097	usd
CY2022Q3	us-gaap	Depreciation And Amortization DepreciationAndAmortization	9097	usd
CY2023Q3	us-gaap	Operating Expenses OperatingExpenses	333136	usd
CY2023Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-333136	usd
CY2022Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-817312	usd
CY2023Q3	us-gaap	Interest Expense InterestExpense	99138	usd
CY2022Q3	us-gaap	Interest Expense InterestExpense	62888	usd
CY2023Q3	dei	Entity Central Index Key EntityCentralIndexKey	0001440799
CY2023Q3	dei	Amendment Flag AmendmentFlag	false
CY2023Q3	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--04-30
CY2023Q3	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2023Q3	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
CY2023Q2	mmex	Discount On Convertible Note In Default DiscountOnConvertibleNoteInDefault	0	usd
CY2023Q2	mmex	Discount On Convertible Note Related Parties DiscountOnConvertibleNoteRelatedParties	0	usd
CY2023Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	10000000000	shares
CY2023Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	4881359425	shares
CY2023Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	769618295	shares
CY2023Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2023Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
CY2023Q3	us-gaap	Gain Loss On Sale Of Derivatives GainLossOnSaleOfDerivatives	0	usd
CY2023Q3	mmex	Warrants Term WarrantsTerm	one-year
CY2022Q3	mmex	Total Shares Issued Of Common Stock TotalSharesIssuedOfCommonStock	3105120	shares
CY2023Q3	mmex	Warrants Modified The Terms Of Description WarrantsModifiedTheTermsOfDescription	Series C and Series D warrants, from $0.10 to $0.05
CY2023Q3	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	3000000	shares
CY2023Q3	mmex	Shares Issued Prefunded Warrants SharesIssuedPrefundedWarrants	5000000	shares
CY2023Q3	mmex	Conversion Of Stock Shares Of Related Party Converted1 ConversionOfStockSharesOfRelatedPartyConverted1	204763	shares
CY2023Q3	mmex	Convertible Common Stock Converted To Other Securities ConvertibleCommonStockConvertedToOtherSecurities	27450	usd
CY2023Q3	mmex	Common Stock Shares Issued Upon Conversion Of Debt Shares CommonStockSharesIssuedUponConversionOfDebtShares	687370	usd
CY2023Q3	us-gaap	Debt Conversion Converted Instrument Warrants Or Options Issued1 DebtConversionConvertedInstrumentWarrantsOrOptionsIssued1	687370	shares
CY2023Q3	dei	Document Type DocumentType	10-Q
CY2023Q3	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2023Q3	dei	Document Period End Date DocumentPeriodEndDate	2023-07-31
CY2023Q3	dei	Document Transition Report DocumentTransitionReport	false
CY2023Q3	dei	Entity File Number EntityFileNumber	000-55831
CY2023Q3	dei	Entity Registrant Name EntityRegistrantName	MMEX RESOURCES CORPORATION
CY2023Q3	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NV
CY2023Q3	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	26-1749145
CY2023Q3	dei	Entity Address Address Line1 EntityAddressAddressLine1	3616 Far West Blvd.
CY2023Q3	dei	Entity Address Address Line2 EntityAddressAddressLine2	#117-321
CY2023Q3	dei	Entity Address City Or Town EntityAddressCityOrTown	Austin
CY2023Q3	dei	Entity Address State Or Province EntityAddressStateOrProvince	TX
CY2023Q3	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	78731
CY2023Q3	dei	City Area Code CityAreaCode	855
CY2023Q3	dei	Local Phone Number LocalPhoneNumber	880-0400
CY2023Q3	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023Q3	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023Q3	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023Q3	dei	Entity Small Business EntitySmallBusiness	true
CY2023Q3	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023Q3	dei	Entity Shell Company EntityShellCompany	false
CY2023Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	5629980114	shares
CY2023Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	10363	usd
CY2023Q3	mmex	Notes Payable Related Party Classified Current NotesPayableRelatedPartyClassifiedCurrent	14962	usd
CY2023Q2	mmex	Notes Payable Related Party Classified Current NotesPayableRelatedPartyClassifiedCurrent	0	usd
CY2023Q3	mmex	Discount On Convertible Note In Default DiscountOnConvertibleNoteInDefault	0	usd
CY2023Q3	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	520890	usd
CY2023Q2	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	333840	usd
CY2023Q2	mmex	Discount On Convertible Note DiscountOnConvertibleNote	15200	usd
CY2023Q3	us-gaap	Convertible Notes Payable ConvertibleNotesPayable	417141	usd
CY2023Q2	us-gaap	Convertible Notes Payable ConvertibleNotesPayable	620675	usd
CY2023Q3	mmex	Discount On Convertible Note Related Parties DiscountOnConvertibleNoteRelatedParties	0	usd
CY2023Q3	mmex	Accounts Payable Related Party Current And Noncurrent AccountsPayableRelatedPartyCurrentAndNoncurrent	0	usd
CY2023Q2	mmex	Accounts Payable Related Party Current And Noncurrent AccountsPayableRelatedPartyCurrentAndNoncurrent	20000	usd
CY2023Q3	us-gaap	Liabilities Current LiabilitiesCurrent	4024703	usd
CY2023Q2	us-gaap	Liabilities Current LiabilitiesCurrent	3977489	usd
CY2023Q3	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	0	usd
CY2023Q2	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	0	usd
CY2023Q3	us-gaap	Liabilities Liabilities	4024703	usd
CY2023Q2	us-gaap	Liabilities Liabilities	3977489	usd
CY2023Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	10000000000	shares
CY2023Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	769618295	shares
CY2023Q3	us-gaap	Common Stock Value CommonStockValue	4881359	usd
CY2023Q2	us-gaap	Common Stock Value CommonStockValue	769618	usd
CY2023Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2023Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	66068897	usd
CY2023Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	69082490	usd
CY2023Q3	us-gaap	Minority Interest MinorityInterest	9871	usd
CY2023Q2	us-gaap	Minority Interest MinorityInterest	9871	usd
CY2023Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-73912877	usd
CY2023Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-72727305	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	-2952747	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	-2865323	usd
CY2023Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1071956	usd
CY2023Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1112166	usd
CY2023Q3	us-gaap	Pre Opening Costs PreOpeningCosts	0	usd
CY2022Q3	us-gaap	Pre Opening Costs PreOpeningCosts	4357	usd
CY2022Q3	us-gaap	Operating Expenses OperatingExpenses	817312	usd
CY2023Q3	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-753298	usd
CY2022Q3	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	16540	usd
CY2023Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-852436	usd
CY2022Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-46348	usd
CY2023Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-1185572	usd
CY2022Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-863660	usd
CY2023Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2022Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-1185572	usd
CY2023Q3	us-gaap	Dividends Dividends	0	usd
CY2022Q3	us-gaap	Dividends Dividends	2534402	usd
CY2023Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-1185572	usd
CY2022Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-3398062	usd
CY2023Q3	mmex	Net Income Loss Per Common Share Basic And Diluted NetIncomeLossPerCommonShareBasicAndDiluted	-0.00
CY2022Q3	mmex	Net Income Loss Per Common Share Basic And Diluted NetIncomeLossPerCommonShareBasicAndDiluted	-0.15
CY2023Q3	mmex	Weighted Average Number Of Common Shares Outstanding Basic And Diluted WeightedAverageNumberOfCommonSharesOutstandingBasicAndDiluted	4300335823	shares
CY2022Q3	mmex	Weighted Average Number Of Common Shares Outstanding Basic And Diluted WeightedAverageNumberOfCommonSharesOutstandingBasicAndDiluted	22560365	shares
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	-1755980	usd
CY2022Q3	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	109677	usd
CY2022Q3	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	495000	usd
CY2022Q3	mmex	Shares Issued For The Exercise Of Warrants Amount SharesIssuedForTheExerciseOfWarrantsAmount	184	usd
CY2022Q3	mmex	Deemed Dividend DeemedDividend	0	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-863660	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	-2014779	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	-2865323	usd
CY2023Q3	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	29389	usd
CY2023Q3	mmex	Stock Issued During Period Value Accrued Liabilities StockIssuedDuringPeriodValueAccruedLiabilities	83736	usd
CY2023Q3	mmex	Stock Issued During Period Value Accrued Liabilities Related Parties StockIssuedDuringPeriodValueAccruedLiabilitiesRelatedParties	892133	usd
CY2023Q3	mmex	Consideration With Debt ConsiderationWithDebt	44367	usd
CY2023Q3	mmex	Consideration With Debt Related Parties ConsiderationWithDebtRelatedParties	20323	usd
CY2023Q3	us-gaap	Stock Issued During Period Value Conversion Of Units StockIssuedDuringPeriodValueConversionOfUnits	0	usd
CY2023Q3	us-gaap	Share Based Compensation ShareBasedCompensation	28200	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-1185572	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	-2952747	usd
CY2023Q3	us-gaap	Profit Loss ProfitLoss	-1185572	usd
CY2022Q3	us-gaap	Profit Loss ProfitLoss	-863660	usd
CY2023Q3	us-gaap	Depreciation And Amortization DepreciationAndAmortization	9097	usd
CY2022Q3	us-gaap	Depreciation And Amortization DepreciationAndAmortization	9097	usd
CY2023Q3	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	24460	usd
CY2022Q3	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	6072	usd
CY2023Q3	us-gaap	Share Based Compensation ShareBasedCompensation	28200	usd
CY2022Q3	us-gaap	Share Based Compensation ShareBasedCompensation	495000	usd
CY2023Q3	mmex	Loan Fees And Penalties Added To Convertible Note LoanFeesAndPenaltiesAddedToConvertibleNote	0	usd
CY2022Q3	mmex	Loan Fees And Penalties Added To Convertible Note LoanFeesAndPenaltiesAddedToConvertibleNote	16500	usd
CY2023Q3	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-753298	usd
CY2022Q3	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	16540	usd
CY2023Q3	us-gaap	Increase Decrease In Prepaid Expenses Other IncreaseDecreaseInPrepaidExpensesOther	-21000	usd
CY2022Q3	us-gaap	Increase Decrease In Prepaid Expenses Other IncreaseDecreaseInPrepaidExpensesOther	-17500	usd
CY2023Q3	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	20563	usd
CY2022Q3	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	23146	usd
CY2023Q3	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	83095	usd
CY2022Q3	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	49317	usd
CY2023Q3	us-gaap	Increase Decrease In Accounts Payable Related Parties IncreaseDecreaseInAccountsPayableRelatedParties	170346	usd
CY2022Q3	us-gaap	Increase Decrease In Accounts Payable Related Parties IncreaseDecreaseInAccountsPayableRelatedParties	29960	usd
CY2023Q3	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-75513	usd
CY2022Q3	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-233608	usd
CY2023Q3	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	0	usd
CY2022Q3	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	0	usd
CY2023Q3	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	0	usd
CY2022Q3	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	0	usd
CY2023Q3	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	35000	usd
CY2022Q3	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	0	usd
CY2023Q3	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	30400	usd
CY2022Q3	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	105000	usd
CY2023Q3	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	0	usd
CY2022Q3	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	0	usd
CY2023Q3	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	0	usd
CY2022Q3	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	0	usd
CY2023Q3	us-gaap	Proceeds From Issuance Of Warrants ProceedsFromIssuanceOfWarrants	0	usd
CY2022Q3	us-gaap	Proceeds From Issuance Of Warrants ProceedsFromIssuanceOfWarrants	0	usd
CY2023Q3	us-gaap	Proceeds From Issuance Of Preferred Stock Preference Stock And Warrants ProceedsFromIssuanceOfPreferredStockPreferenceStockAndWarrants	0	usd
CY2022Q3	us-gaap	Proceeds From Issuance Of Preferred Stock Preference Stock And Warrants ProceedsFromIssuanceOfPreferredStockPreferenceStockAndWarrants	0	usd
CY2023Q3	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	0	usd
CY2022Q3	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	0	usd
CY2023Q3	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	65400	usd
CY2022Q3	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	105000	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-10113	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-128608	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	10363	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	136867	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	250	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	8259	usd
CY2023Q3	us-gaap	Interest Paid Net InterestPaidNet	9930	usd
CY2022Q3	us-gaap	Interest Paid Net InterestPaidNet	0	usd
CY2023Q3	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	0	usd
CY2022Q3	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	0	usd
CY2023Q3	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	29389	usd
CY2022Q3	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	109677	usd
CY2023Q3	mmex	Warrants Exercises For An Accrued Liability WarrantsExercisesForAnAccruedLiability	0	usd
CY2022Q3	mmex	Warrants Exercises For An Accrued Liability WarrantsExercisesForAnAccruedLiability	184	usd
CY2023Q3	mmex	Common Stock Issued For Accrued Expenses CommonStockIssuedForAccruedExpenses	17808	usd
CY2022Q3	mmex	Common Stock Issued For Accrued Expenses CommonStockIssuedForAccruedExpenses	0	usd
CY2023Q3	mmex	Common Stock Issued For Accrued Expenses Related Parties CommonStockIssuedForAccruedExpensesRelatedParties	204763	usd
CY2022Q3	mmex	Common Stock Issued For Accrued Expenses Related Parties CommonStockIssuedForAccruedExpensesRelatedParties	0	usd
CY2023Q3	mmex	Shares And Warrants Issued For Debt Discount SharesAndWarrantsIssuedForDebtDiscount	44367	usd
CY2022Q3	mmex	Shares And Warrants Issued For Debt Discount SharesAndWarrantsIssuedForDebtDiscount	0	usd
CY2023Q3	mmex	Related Party Accounts Payable Exchanged For Related Party Convertible Note RelatedPartyAccountsPayableExchangedForRelatedPartyConvertibleNote	20323	usd
CY2022Q3	mmex	Related Party Accounts Payable Exchanged For Related Party Convertible Note RelatedPartyAccountsPayableExchangedForRelatedPartyConvertibleNote	0	usd
CY2023Q3	mmex	Stock Issued During Period Value Conversion Of Unit StockIssuedDuringPeriodValueConversionOfUnit	301724	usd
CY2022Q3	mmex	Stock Issued During Period Value Conversion Of Unit StockIssuedDuringPeriodValueConversionOfUnit	0	usd
CY2023Q3	mmex	Exercise Of Prefunded Warrants ExerciseOfPrefundedWarrants	0	usd
CY2022Q3	mmex	Exercise Of Prefunded Warrants ExerciseOfPrefundedWarrants	2494	usd
CY2023Q3	us-gaap	Dividends Dividends	0	usd
CY2022Q3	us-gaap	Dividends Dividends	2534402	usd
CY2023Q3	us-gaap	Use Of Estimates UseOfEstimates	<p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:45px">The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, and the disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</p>
CY2023Q2	mmex	Less Discount LessDiscount	0	usd
CY2023Q3	us-gaap	Share Based Compensation ShareBasedCompensation	28200	usd
CY2022Q3	us-gaap	Share Based Compensation ShareBasedCompensation	495000	usd
CY2023Q3	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<p style="font-size:10pt;font-family:times new roman;margin:0px;text-indent:45px">Certain amounts in the consolidated financial statements for the prior year have been reclassified to conform with the current year presentation.</p>
CY2023Q3	mmex	Accounts Payables Related Parties Current AccountsPayablesRelatedPartiesCurrent	431286	usd
CY2023Q2	mmex	Accounts Payables Related Parties Current AccountsPayablesRelatedPartiesCurrent	465703	usd
CY2023Q3	us-gaap	Insurance Commissions And Fees InsuranceCommissionsAndFees	20000	usd
CY2023Q3	us-gaap	Debt Instrument Unamortized Discount Current DebtInstrumentUnamortizedDiscountCurrent	0	usd
CY2023Q2	us-gaap	Debt Instrument Unamortized Discount Current DebtInstrumentUnamortizedDiscountCurrent	0	usd
CY2023Q3	mmex	Convertible Notes Payables ConvertibleNotesPayables	0	usd
CY2023Q2	mmex	Convertible Notes Payables ConvertibleNotesPayables	20000	usd
CY2023Q1	us-gaap	Convertible Preferred Stock Converted To Other Securities ConvertiblePreferredStockConvertedToOtherSecurities	20000	usd
CY2023Q1	us-gaap	Debt Instrument Convertible Threshold Percentage Of Stock Price Trigger DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger	1.10	pure
CY2023Q3	us-gaap	Interest On Convertible Debt Net Of Tax InterestOnConvertibleDebtNetOfTax	0	usd
CY2022Q3	us-gaap	Interest On Convertible Debt Net Of Tax InterestOnConvertibleDebtNetOfTax	175	usd
CY2023Q3	mmex	Notes Payable Related Parties Classified Gross NotesPayableRelatedPartiesClassifiedGross	35872	usd
CY2023Q2	mmex	Notes Payable Related Parties Classified Gross NotesPayableRelatedPartiesClassifiedGross	0	usd
CY2023Q3	mmex	Less Discount LessDiscount	-20910	usd
CY2023Q3	mmex	Notes Payable Related Party Classified Current NotesPayableRelatedPartyClassifiedCurrent	14962	usd
CY2023Q2	mmex	Notes Payable Related Party Classified Current NotesPayableRelatedPartyClassifiedCurrent	0	usd
CY2023Q3	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	1247688	usd
CY2023Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	1247877	usd
CY2023Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	178982	usd
CY2023Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	170074	usd
CY2023Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1068706	usd
CY2023Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1077803	usd
CY2023Q3	us-gaap	Depreciation And Amortization DepreciationAndAmortization	9097	usd
CY2022Q3	us-gaap	Depreciation And Amortization DepreciationAndAmortization	9097	usd
CY2023Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1049099	usd
CY2023Q2	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	985751	usd
CY2021Q1	us-gaap	Debt Instrument Maturity Date DebtInstrumentMaturityDate	2022-03-11
CY2021Q1	us-gaap	Debt Instrument Interest Rate During Period DebtInstrumentInterestRateDuringPeriod	0.10	pure
CY2023Q3	mmex	Convertible Note Payable Currently In Default ConvertibleNotePayableCurrentlyInDefault	185100	usd
CY2023Q2	mmex	Convertible Note Payable Currently In Default ConvertibleNotePayableCurrentlyInDefault	120200	usd
CY2023Q3	mmex	Convertible Notes Payable Discount ConvertibleNotesPayableDiscount	-60148	usd
CY2023Q2	mmex	Convertible Notes Payable Discount ConvertibleNotesPayableDiscount	-14490	usd
CY2023Q3	mmex	Convertible Notes Payable Currently In Default Net Of Discount ConvertibleNotesPayableCurrentlyInDefaultNetOfDiscount	124952	usd
CY2023Q2	mmex	Convertible Notes Payable Currently In Default Net Of Discount ConvertibleNotesPayableCurrentlyInDefaultNetOfDiscount	105710	usd
CY2023Q3	mmex	Convertible Notes Payable Currently In Default ConvertibleNotesPayableCurrentlyInDefault	520890	usd
CY2023Q2	mmex	Convertible Notes Payable Currently In Default ConvertibleNotesPayableCurrentlyInDefault	333840	usd
CY2023Q3	mmex	Convertible Note Payable Discount ConvertibleNotePayableDiscount	0	usd
CY2023Q2	mmex	Convertible Note Payable Discount ConvertibleNotePayableDiscount	0	usd
CY2023Q3	mmex	Convertible Note Payable Currently In Default Net Of Discount ConvertibleNotePayableCurrentlyInDefaultNetOfDiscount	520890	usd
CY2023Q2	mmex	Convertible Note Payable Currently In Default Net Of Discount ConvertibleNotePayableCurrentlyInDefaultNetOfDiscount	333840	usd
CY2022Q2	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	165000	usd
CY2022Q2	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	155000	usd
CY2022Q2	us-gaap	Costs And Expenses CostsAndExpenses	10000	usd
CY2022Q2	mmex	Note Desceription NoteDesceription	The Company can prepay the note with prepayment penalties ranging from 105% to 125% during the first 180 days after issuance. During the three months ended July 31, 2023 the Company converted $12,950 into 256,708,619 shares of common stock
CY2023Q3	mmex	Convertible Notes Payable Total ConvertibleNotesPayableTotal	421375	usd
CY2023Q2	mmex	Convertible Notes Payable Total ConvertibleNotesPayableTotal	635875	usd
CY2023Q3	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	4234	usd
CY2023Q2	us-gaap	Debt Instrument Unamortized Discount DebtInstrumentUnamortizedDiscount	15200	usd
CY2023Q3	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable	417141	usd
CY2023Q2	us-gaap	Convertible Long Term Notes Payable ConvertibleLongTermNotesPayable	620675	usd
CY2023Q3	mmex	Capital Stock Authorized CapitalStockAuthorized	10001000000	shares
CY2023Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	10000000000	shares
CY2023Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
CY2023Q3	mmex	Total Shares Issued Of Common Stock TotalSharesIssuedOfCommonStock	4111741130	shares
CY2023Q3	us-gaap	Debt Conversion Original Debt Amount1 DebtConversionOriginalDebtAmount1	27450	usd
CY2023Q3	us-gaap	Line Of Credit Facility Increase Accrued Interest LineOfCreditFacilityIncreaseAccruedInterest	1399	usd
CY2023Q3	us-gaap	Payments For Fees PaymentsForFees	540	usd
CY2023Q3	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	279120377	usd
CY2023Q3	mmex	Shares Issued For Accrued Liability Related Parties Share SharesIssuedForAccruedLiabilityRelatedPartiesShare	17808	shares
CY2023Q3	mmex	Shares Issued For Exercise Of Prefunded Warrants SharesIssuedForExerciseOfPrefundedWarrants	3174187995	shares
CY2023Q3	mmex	Shares Issued For A Debt Discount Value SharesIssuedForADebtDiscountValue	204763	usd
CY2023Q3	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	892133	usd
CY2023Q3	mmex	Warrants To Purchase Share WarrantsToPurchaseShare	687370	shares
CY2023Q3	us-gaap	Stock Issued During Period Shares Other StockIssuedDuringPeriodSharesOther	710802	shares
CY2022Q3	mmex	Common Stock Shares Issued Upon Conversion Of Debt Shares CommonStockSharesIssuedUponConversionOfDebtShares	109677	usd
CY2022Q3	us-gaap	Debt Conversion Original Debt Amount1 DebtConversionOriginalDebtAmount1	90000	usd
CY2022Q3	us-gaap	Line Of Credit Facility Increase Accrued Interest LineOfCreditFacilityIncreaseAccruedInterest	19677	usd
CY2022Q3	mmex	Shares Issued Prefunded Warrants SharesIssuedPrefundedWarrants	2494318	shares
CY2023Q3	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	0.000116
CY2023Q3	mmex	Warrant Grant WarrantGrant	3000000	shares
CY2023Q3	mmex	Warrants Issued As Stock Based Compensation WarrantsIssuedAsStockBasedCompensation	28200	usd
CY2023Q3	mmex	Shares Issued For A Debt Discount Shares SharesIssuedForADebtDiscountShares	398119123	shares
CY2023Q3	mmex	Shares Issued For Accrued Liability Related Parties Value SharesIssuedForAccruedLiabilityRelatedPartiesValue	20323	usd
CY2023Q3	us-gaap	Conversion Of Stock Shares Converted1 ConversionOfStockSharesConverted1	613479624	shares
CY2023Q3	mmex	Common Stock Shares Issued For Conversion Of Convertible Note Value CommonStockSharesIssuedForConversionOfConvertibleNoteValue	44367	usd
CY2022Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	4881359425	shares
CY2023Q3	us-gaap	Conversion Of Stock Shares Issued1 ConversionOfStockSharesIssued1	25001000000	shares
CY2023Q3	mmex	Shares Issued For Accrued Liabilities SharesIssuedForAccruedLiabilities	25000000000	shares
CY2023Q3	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	1000000	usd

Files In Submission

Name	View Source	Status
0001477932-23-006808-index-headers.html	Edgar Link	pending
0001477932-23-006808-index.html	Edgar Link	pending
0001477932-23-006808.txt	Edgar Link	pending
0001477932-23-006808-xbrl.zip	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
mmex-20230731.xsd	Edgar Link	pending
mmex_10q.htm	Edgar Link	pending
mmex_ex311.htm	Edgar Link	pending
mmex_ex321.htm	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
mmex-20230731_cal.xml	Edgar Link	unprocessable
mmex-20230731_def.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
mmex-20230731_pre.xml	Edgar Link	unprocessable
mmex-20230731_lab.xml	Edgar Link	unprocessable
mmex_10q_htm.xml	Edgar Link	completed
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$MMEX
MMEX Resources Corp Stock $mmex

2023 Q3 Form 10-Q Financial Statement

#000147793223006808 Filed on September 11, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$MMEX MMEX Resources Corp Stock $mmex

2023 Q3 Form 10-Q Financial Statement

#000147793223006808 Filed on September 11, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$MMEX
MMEX Resources Corp Stock $mmex